recombinant SARS-CoV-2 ∆ORF3a
virus

recombinant SARS-CoV-2 ∆ORF3a

EVAg
Produced by
: UNIBAS
Shipping From
: Basel - CH

Product Description

Ref-SKU:
007V-06287
Recombinant SARS-CoV-2 with deletion of orf3a. Virus was produced using the CLEVER method as described in (doi: 10.7554/eLife.89035). Region of interest sequenced.
Product Risk Group: 
RG3
ICTV Taxonomy: 
Riboviria / Orthornavirae / Pisuviricota / Pisoniviricetes / Nidovirales / Cornidovirineae / Coronaviridae / Orthocoronavirinae / Betacoronavirus
Virus name: 
SARS-CoV-2; Severe acute respiratory syndrome coronavirus 2

Storage conditions: 
Viral Storage Medium -80C
Sequencing: 
Partial sequence
Infectivity: 
Infectivity tested
Mycoplasmic content: 
Mycoplasma free

Unit definition: 
1mL of virus stock, >4E5 PFU/ml

In stock

2 000,00 €
 (Cost per access for Academics)
Free access available

catalogue

biobank

Portal

EVAg

purchase

buy

order

price

cost

shipping

shipment

experiment

research

laboratory

viral

virus

GMO: 
Yes
Virus host type: 
Human virus
Infectivity Test: 
Infection of Vero E6-TMPRSS2 cells, plaque formation assay, intracellular N detection
Production cell line: 
TMPRSS2-expressing VeroE6
Virus Cultivability: 
Cultivable virus
Related DOI: 
doi: 10.7554/eLife.89035
Shipping conditions: 
Dry ice
IATA Classification: 
Category A, UN2814

Information about the collection of the virus

Recombinant product: 
No
Biological material origin: 
Synthetic origin
Modifications from the reference sequence(s): 
The sequence(s) of this synthetic product has NOT been modified from the sequence listing provided as Genbank references